Search for: "Teva USA"
Results 361 - 380
of 714
Sorted by Relevance
|
Sort by Date
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
8 Oct 2009, 6:05 am
Teva, Mylan, Dr. [read post]
29 Feb 2008, 1:50 am
Teva Pharmaceuticals USA, Inc., No. 04-940-JJF (D.Del. [read post]
6 Oct 2010, 11:43 pm
USA v. [read post]
31 Mar 2014, 2:16 pm
The Supreme Court today granted certiorari in Teva Pharmaceuticals USA, Inc. v. [read post]
11 Dec 2008, 10:30 pm
(DRL); and Teva Pharmaceuticals USA, Inc. [read post]
19 Apr 2010, 1:34 pm
USA, Inc., 557 F.3d 1346 (Fed. [read post]
24 Aug 2021, 2:10 am
USA Inc., No. 20-1630 (D. [read post]
9 May 2017, 9:49 am
By Dennis Crouch Nestle USA v. [read post]
10 Nov 2014, 2:18 pm
USA, Inc. v. [read post]
3 Jun 2016, 9:55 am
Teva Pharm. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
11 Sep 2018, 9:16 am
Teva Pharma USA, Inc. [read post]
13 Jul 2018, 5:48 pm
Teva Parenteral Meds. [read post]
25 Feb 2020, 2:10 am
Teva Pharmaceuticals USA, Inc., is a non-precedential decision that was issued on the briefs (without oral argument), but is worth reviewing for its discussion of anticipation and inherency in the context of method of treatment claims. [read post]
7 Sep 2010, 6:10 pm
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin Amgen,… [read post]
2 Jan 2008, 9:05 pm
(with its Teva Pharmaceuticals USA, Inc., subsidiary), both of which filed two patent infringement lawsuits in Maryland last year. [read post]
26 Aug 2009, 6:12 am
F. of L. files antitrust suit against Merck, alleging fraudulent procurement of a patent, improper listing of patent in Orange Book (Patent Docs) Singulair (Montelukast) – US: Merck get injunction preventing Teva from selling generic Montelukast: Merck Sharp & Dohme Pharmaceuticals SRL v Teva Pharmaceuticals USA (The IP Factor) (IP Watchdog) (SmartBrief) (SmartBrief) (GenericsWeb) [read post]
28 Jul 2010, 12:06 am
Teva Pharmaceuticals USA, Inc. [read post]
8 Oct 2009, 12:37 pm
Teva Pharmaceuticals USA, Inc. 518 F.3d 1353 (Fed. [read post]
